Apogee Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03770N1019

SecurityAPGE / Apogee Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership598,902 shares
Latest Disclosed Value $ 50,409,581
Citadel Advisors Llc ownership in APGE / Apogee Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 598,902 shares of Apogee Therapeutics, Inc. (US:APGE) valued at $50,409,581 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 766,981 shares of Apogee Therapeutics, Inc.. This represents a change in shares of -21.91% during the quarter. The current value of the position is $52,056,562 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (APGE) in the form of stock options. The firm currently holds call options representing 33,700 of underlying shares valued at $2,836,529 USD and put options representing 20,000 of underlying shares valued at $1,683,400 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APGE / Apogee Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F APOGEE THERAPEUTICS COM 03770N101 598,902 -168,079 -21.91 50,410 -12.92 0.0072
2026-02-17 2025-12-31 13F APOGEE THERAPEUTICS COM 03770N101 766,981 -402,263 -34.40 57,892 24.62 0.0087
2025-11-14 2025-09-30 13F APOGEE THERAPEUTICS COM 03770N101 1,169,244 673,585 135.90 46,454 115.80 0.0071
2025-08-14 2025-06-30 13F APOGEE THERAPEUTICS COM 03770N101 495,659 429,477 648.93 21,526 770.79 0.0037
2025-05-15 2025-03-31 13F APOGEE THERAPEUTICS COM 03770N101 66,182 -6,542 -9.00 2,473 -24.95 0.0005
2025-02-14 2024-12-31 13F APOGEE THERAPEUTICS COM 03770N101 72,724 72,724 3,294 0.0006
2024-11-14 2024-09-30 13F APOGEE THERAPEUTICS COM 03770N101 0 -116,318 -100.00 0 -100.00
2024-08-14 2024-06-30 13F APOGEE THERAPEUTICS COM 03770N101 116,318 116,318 4,577 0.0009
2024-02-14 2023-12-31 13F APOGEE THERAPEUTICS COM 03770N101 0 -243,126 -100.00 0 -100.00
2023-11-14 2023-09-30 13F APOGEE THERAPEUTICS COM 03770N101 243,126 243,126 5,179 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APOGEE THERAPEUTICS COM Call 33,700 137.32 2,837 164.80 n/a n/a n/a
2026-02-17 2025-12-31 13F APOGEE THERAPEUTICS COM Call 14,200 -30.73 1,072 31.57 n/a n/a n/a
2025-11-14 2025-09-30 13F APOGEE THERAPEUTICS COM Call 20,500 76.72 814 61.83 n/a n/a n/a
2025-08-14 2025-06-30 13F APOGEE THERAPEUTICS COM Call 11,600 48.72 504 72.85 n/a n/a n/a
2025-05-15 2025-03-31 13F APOGEE THERAPEUTICS COM Call 7,800 151.61 291 107.86 n/a n/a n/a
2025-02-14 2024-12-31 13F APOGEE THERAPEUTICS COM Call 3,100 -62.65 140 -71.25 n/a n/a n/a
2024-11-14 2024-09-30 13F APOGEE THERAPEUTICS COM Call 8,300 277.27 488 466.28 n/a n/a n/a
2024-08-14 2024-06-30 13F APOGEE THERAPEUTICS COM Call 2,200 1,000.00 87 561.54 n/a n/a n/a
2024-05-15 2024-03-31 13F APOGEE THERAPEUTICS COM Call 200 13 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F APOGEE THERAPEUTICS COM Put 20,000 26.58 1,683 41.19 n/a n/a n/a
2026-02-17 2025-12-31 13F APOGEE THERAPEUTICS COM Put 15,800 110.67 1,193 301.35 n/a n/a n/a
2025-11-14 2025-09-30 13F APOGEE THERAPEUTICS COM Put 7,500 298 n/a n/a n/a
2025-08-14 2025-06-30 13F APOGEE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F APOGEE THERAPEUTICS COM Put 20,100 673.08 751 541.03 n/a n/a n/a
2025-02-14 2024-12-31 13F APOGEE THERAPEUTICS COM Put 2,600 420.00 118 303.45 n/a n/a n/a
2024-11-14 2024-09-30 13F APOGEE THERAPEUTICS COM Put 500 -93.24 29 -90.03 n/a n/a n/a
2024-08-14 2024-06-30 13F APOGEE THERAPEUTICS COM Put 7,400 45.10 291 -13.91 n/a n/a n/a
2024-05-15 2024-03-31 13F APOGEE THERAPEUTICS COM Put 5,100 339 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.